4.7 Article

Selenium-containing naphthalimides as anticancer agents: Design, synthesis and bioactivity

Journal

BIOORGANIC & MEDICINAL CHEMISTRY
Volume 20, Issue 8, Pages 2558-2563

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2012.02.049

Keywords

Anticancer; Naphthalimides; Selenium; K562; DNA

Funding

  1. National Basic Research Program of China (973 Program) [2010CB126100]
  2. National High Technology Research, the Development Program of China (863 Program) [2011AA10A207]
  3. National Key Technology R&D Program of China [2011BAE06B01]
  4. Fundamental Research Funds for the Central Universities

Ask authors/readers for more resources

Selenium analogues (4b-4h, and 4j) of two known sulfur compounds were synthesized and tested their anticancer activities. The selenium compound 4b had comparable activity with its sulfur analogue 4a, while DNA-binding study showed these two compounds had similar interaction with ct-DNA, the K-b was 8.23 and 2.36, respectively. The primary results showed that most compounds had moderate anticancer activities with IC50 values between 10 (6) and 10 (5) M. Another selenium analogue 4j showed the highest activity with the IC50 values around 5.3 mu M against K562 and MCF-7 cell lines. More importantly, the organochalcogen compounds exhibited stronger anticancer activities against K562 cell line than the other cell lines tested. Crown Copyright (C) 2012 Published by Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available